© 2010

Advances in Schizophrenia Research 2009

  • Wagner F. Gattaz
  • Geraldo Busatto

Table of contents

  1. Front Matter
    Pages i-xv
  2. Epidemiology And Risk Factors

  3. Pathophysiology

    1. Front Matter
      Pages 97-97
    2. B. Moghaddam, A.L. Pehrson
      Pages 99-111
    3. Geraldo F. Busatto, Marcus V. Zanetti, Maristela S. Schaufelberger, José A.S. Crippa
      Pages 113-148
    4. Peter Falkai, Eleni Parlapani, Oliver Gruber, Andrea Schmitt
      Pages 149-165
  4. Genetics

    1. Front Matter
      Pages 173-173
    2. Emmanuel Dias-Neto, Daniel Martins-de-Souza, Elida P.B. Ojopi, Wagner F. Gattaz
      Pages 193-218
    3. Renan P. Souza, Marco A. Romano Silva, James L. Kennedy
      Pages 233-248
  5. Psychopathology, Cognition, Outcome

About this book


Advances in Schizophrenia Research 2009

Edited by Wagner F. Gattaz and Gerardo Busatto


Schizophrenia stands as a major psychiatric mystery: devastating to patients and families, resistant to treatment, burdened by stigma, causes unknown. As interest and research in the disorder continue worldwide, new sources for comprehensive reviews of cutting-edge studies are of growing importance. The leadoff volume of Advances in Schizophrenia Research 2009 fills this need with welcome innovation and scientific rigor.

Presenting papers from the recent Symposium on the Search for the Causes of Schizophrenia, leading scientists offer latest findings, promising theories, relevant controversies, and emerging frontiers, in areas as varied as commonalities with other psychotic disorders and the impact of social factors on rehabilitation. Whether one’s interest is in prevalence, genetics, risk factors, neuropathology, diagnostic boundaries, or treatment options, the discussion includes a number of intriguing and informative perspectives.

A sampling of the topics covered:

  • Incidence and outcome of schizophrenia: the view from around the world.
  • Schizophrenia: neurodevelopmental, neurodegenerative, or both?
  • The molecular genetics and proteomics of schizophrenia.
  • Marijuana use: distraction from the issues, or key to the disease?
  • Antipsychotic drug treatment: facts and fiction
  • The case for schizophrenia as cognitive disorder.

This wide-ranging coverage makes Advances in Schizophrenia Research 2009 a reference for professionals in clinical psychology, psychiatry, neuropsychology and other mental health workers, promoting more nuanced understanding of the disease, providing deeper insights into its management, and inspiring new possibilities for practice and research.


Antipsychotics Community care for schizop Dopamine Genetics of schizophrenia Incidence of schizophrenia Models of schizophrenia Pharmacogenomics in schizophrenia Prevalence of schizophrenia Schizophrenia Syndrom genetics intervention neurons psychiatry rehabilitation

Editors and affiliations

  • Wagner F. Gattaz
    • 1
  • Geraldo Busatto
    • 2
  1. 1.Fac. MedicinaUniversidade de São PauloSao PauloBrazil
  2. 2.Fac. MedicinaUniversidade de São PauloSao PauloBrazil

Bibliographic information

Industry Sectors
Health & Hospitals
Consumer Packaged Goods


From the reviews: “The book is a comprehensive update of the recent developments in schizophrenia research … . book represents the state of affairs in schizophrenia research. … The target audience includes ‘professionals in clinical psychology, psychiatry, neuropsychology, and other mental health workers.’ … This book will provide readers with the current research findings in schizophrenia from the ‘one diseasers’ (analogous to the flat earthers!). However, researchers in schizophrenia will find it a useful reference.” (Michael Joel Schrift, Doody’s Review Service, May, 2010)